Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia
- Conditions
- ObesityDyslipidemia
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2008-12-19
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 345
- Registration Number
- NCT00345410
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Risedronate in Osteopenic Postmenopausal Women
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 156
- Registration Number
- NCT00345644
- Locations
- 🇫🇷
Sanofi-Aventis, Paris, France
Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
- Conditions
- ThrombosisEmbolism
- Interventions
- Drug: Placebo (for idrabiotaparinux sodium)Drug: Placebo (for warfarin)
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 3202
- Registration Number
- NCT00345618
- Locations
- 🇷🇺
Sanofi-Aventis Admnistrative Office, Moscow, Russian Federation
🇬🇧Sanofi-Aventis Administrative Office, Guildford Surrey, United Kingdom
🇦🇺sanofi-aventis Australia & New Zealand administrative office, Macquarie Park, New South Wales, Australia
A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
- Conditions
- Depressive DisorderMajor Depression
- First Posted Date
- 2006-06-27
- Last Posted Date
- 2009-03-12
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 704
- Registration Number
- NCT00345098
- Locations
- 🇿🇦
Sanofi-Aventis Administrative Office, Midrand, South Africa
Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults
- First Posted Date
- 2006-06-27
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 77
- Registration Number
- NCT00344942
- Locations
- 🇫🇷
Sanofi-Aventis, Paris, France
Docetaxel in Locally Advanced Gastric Adenocarcinoma
- Conditions
- Stomach Neoplasms
- Interventions
- First Posted Date
- 2006-06-22
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 59
- Registration Number
- NCT00343239
- Locations
- 🇹🇷
Sanofi-Aventis Administrative Office, Istanbul, Turkey
DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP)
- Conditions
- Acute Low Back Pain
- First Posted Date
- 2006-06-22
- Last Posted Date
- 2009-09-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 2830
- Registration Number
- NCT00343057
- Locations
- 🇫🇷
Sanofi-Aventis, Paris, France
Dose Ranging Study in Elective Total Hip Replacement Surgery
- Conditions
- Venous Thromboembolism
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2008-12-10
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1090
- Registration Number
- NCT00338897
- Locations
- 🇹🇷
Sanofi-Aventis, Istanbul, Turkey
Alfuzosin for Treating Acute Urinary Retention
- First Posted Date
- 2006-06-15
- Last Posted Date
- 2009-09-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 156
- Registration Number
- NCT00336921
- Locations
- 🇨🇳
Sanofi-aventis, Beijing, China
A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)
- First Posted Date
- 2006-06-14
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 430
- Registration Number
- NCT00336713
- Locations
- 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States